The price of Retatrutide, a new medication for obesity , is initially a substantial factor for many. Anticipate a steep charge , potentially ranging from $initial_low to $initial_high per month depending on individual coverage and the prescription. Absent insurance , the financial burden can be rather substantial, and patient must consider accessib